首页> 外文期刊>Rambam Maimonides Medical Journal >Effectiveness of Inferior Vena Cava Filters without Anticoagulation Therapy for Prophylaxis of Recurrent Pulmonary Embolism
【24h】

Effectiveness of Inferior Vena Cava Filters without Anticoagulation Therapy for Prophylaxis of Recurrent Pulmonary Embolism

机译:没有抗凝治疗的下腔静脉滤器预防复发性肺栓塞的有效性

获取原文
           

摘要

Objective The optimal treatment of deep vein thrombosis (DVT) is anticoagulation therapy. Inferior vena cava filter (IVC) placement is another option for the prevention of pulmonary embolism (PE) in patients with deep vein thrombosis. This is used mostly in patients with a contraindication to anticoagulant therapy. The purpose of the present study was to compare the two options. Methods A retrospective cohort study of two groups of patients with DVT: patients who received an IVC filter and did not receive anticoagulation due to contraindications; and patients with DVT and similar burden of comorbidity treated with anticoagulation without IVC insertion. To adjust for a potential misbalance in baseline characteristics between the two groups, we performed matching for age, gender, and Charlson’s index, which is used to compute the burden of comorbid conditions. The primary outcome was an occurrence of a PE. Results We studied 1,742 patients hospitalized with the diagnosis of DVT in our hospital;93 patients from this population received IVC filters. Charlson’s score index was significantly higher in the IVC filter group compared with the anticoagulation group. After matching of the groups of patients according to Charlson’s score index there were no significant differences in primary outcomes. Conclusion Inferior vena cava filter without anticoagulation may be an alternative option for prevention of PE in patients with contraindications to anticoagulant therapy.
机译:目的深静脉血栓形成(DVT)的最佳治疗方法是抗凝治疗。下腔静脉滤器(IVC)的放置是预防深静脉血栓形成患者肺栓塞(PE)的另一种选择。这主要用于有抗凝治疗禁忌症的患者。本研究的目的是比较两种选择。方法对两组DVT患者进行回顾性队列研究:接受IVC滤过器且因禁忌症未接受抗凝治疗的患者; DVT和合并症的类似负担的患者接受抗凝治疗,无需插入IVC。为了调整两组之间基线特征的潜在失衡,我们对年龄,性别和查尔森指数进行了匹配,该指数用于计算合并症的负担。主要结局是发生PE。结果我们研究了在我院诊断为DVT住院的1,742例患者;该人群​​中的93例患者接受了IVC过滤器。与抗凝组相比,IVC滤过组的查尔森评分指数显着更高。在根据Charlson评分指数对患者分组进行匹配之后,主要结局没有显着差异。结论不采用抗凝治疗的下腔静脉滤器可能是预防抗凝治疗禁忌症患者PE的另一种选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号